Mirati Therapeutics, Inc (MRTX) Covered Calls

Mirati Therapeutics, Inc covered calls Mirati Therapeutics Inc is a biopharmaceutical company that discovers, develops, and commercializes novel therapeutics with an initial focus on cancer and infectious diseases.

You can sell covered calls on Mirati Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MRTX (prices last updated Fri 12:15 PM ET):

Mirati Therapeutics, Inc (MRTX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
106.14 +0.25 105.98 106.39 54K -22.6 3.8B
Covered Calls For Mirati Therapeutics, Inc (MRTX)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 105 5.30 101.09 3.9% 49.1%
Sep 20 105 7.60 98.79 6.3% 35.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing a pipeline of targeted oncology products. It also focuses on its development programs on drugs intended to treat specific subsets of cancer patients with unmet needs. The company's pipeline consists of three product candidates: MGCD265, MGCD516 and mocetinostat. MGCD265 and MGCD516 are orally-bioavailable, multi-targeted kinase inhibitors with distinct target profiles that are in development to treat patients with non-small cell lung cancer, or NSCLC, squamous cell carcinoma of the head and neck, or HNSCC, and other solid tumor. Mirati Therapeutics was founded on December 13, 1995 and is headquartered in San Diego, CA.